Zomedica Corp [ZOM] stock prices are down -3.13% to $0.14 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ZOM shares have gain 17.51% over the last week, with a monthly amount glided 9.97%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zomedica Corp [AMEX: ZOM] stock has seen the most recent analyst activity on January 06, 2023, when Dawson James initiated its Buy rating and assigned the stock a price target of $6.
The stock price of Zomedica Corp [ZOM] has been fluctuating between $0.12 and $0.20 over the past year. Zomedica Corp [AMEX: ZOM] shares were valued at $0.14 at the most recent close of the market.
Analyzing the ZOM fundamentals
The Zomedica Corp [AMEX:ZOM] reported sales of 26.73M for trailing twelve months, representing a surge of 10.24%. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at -1.43%, Pretax Profit Margin comes in at -2.32%, and Net Profit Margin reading is -2.33%. To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.28 and Total Capital is -0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1384 points at the first support level, and at 0.1346 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1497, and for the 2nd resistance point, it is at 0.1572.
Ratios To Look Out For
It’s worth pointing out that Zomedica Corp [AMEX:ZOM]’s Current Ratio is 10.82. Further, the Quick Ratio stands at 10.15, while the Cash Ratio is 1.21. Considering the valuation of this stock, the price to sales ratio is 5.55, the price to book ratio is 0.69.
Transactions by insiders
Recent insider trading involved Blair Anthony K, COO, that happened on Nov 08 ’24 when 0.15 million shares were purchased. Director, POWERS JOHNNY D completed a deal on Nov 11 ’24 to buy 100000.0 shares. Meanwhile, CEO HEATON LARRY C II bought 100000.0 shares on Nov 11 ’24.
